CINECA IRIS Institutional Research Information System

MICCOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.634
AS - Asia 9.249
EU - Europa 7.390
SA - Sud America 1.209
AF - Africa 333
Continente sconosciuto - Info sul continente non disponibili 278
OC - Oceania 29
Totale 40.122
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.875
SG - Singapore 2.854
CN - Cina 2.808
IT - Italia 2.683
HK - Hong Kong 1.375
SE - Svezia 1.131
BR - Brasile 993
BG - Bulgaria 633
VN - Vietnam 609
CA - Canada 570
DE - Germania 553
GB - Regno Unito 487
TR - Turchia 410
KR - Corea 397
UA - Ucraina 391
FR - Francia 347
FI - Finlandia 346
RU - Federazione Russa 284
IN - India 204
CH - Svizzera 171
AT - Austria 106
JP - Giappone 105
BD - Bangladesh 97
CI - Costa d'Avorio 84
AR - Argentina 74
IQ - Iraq 63
NL - Olanda 58
BE - Belgio 47
SN - Senegal 46
MX - Messico 45
SA - Arabia Saudita 43
PK - Pakistan 40
NG - Nigeria 39
ZA - Sudafrica 37
JM - Giamaica 32
VE - Venezuela 31
CO - Colombia 28
EC - Ecuador 26
EG - Egitto 26
CR - Costa Rica 25
PL - Polonia 25
MA - Marocco 23
ID - Indonesia 22
JO - Giordania 21
TN - Tunisia 20
UZ - Uzbekistan 20
AU - Australia 19
ES - Italia 19
KE - Kenya 19
IE - Irlanda 18
AE - Emirati Arabi Uniti 17
MY - Malesia 17
PE - Perù 17
IR - Iran 16
TT - Trinidad e Tobago 16
IL - Israele 15
UY - Uruguay 14
KZ - Kazakistan 13
NP - Nepal 13
CL - Cile 12
PH - Filippine 12
OM - Oman 10
BB - Barbados 9
BO - Bolivia 9
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
EE - Estonia 9
GT - Guatemala 9
NZ - Nuova Zelanda 9
PT - Portogallo 9
DK - Danimarca 8
HN - Honduras 8
LT - Lituania 8
AZ - Azerbaigian 7
BJ - Benin 7
GR - Grecia 7
PA - Panama 7
RO - Romania 7
DZ - Algeria 6
HU - Ungheria 6
NI - Nicaragua 6
SV - El Salvador 6
LB - Libano 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
TW - Taiwan 5
AM - Armenia 4
AO - Angola 4
BY - Bielorussia 4
ET - Etiopia 4
GE - Georgia 4
HR - Croazia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
QA - Qatar 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
BS - Bahamas 3
BZ - Belize 3
Totale 39.779
Salva come PNG Salva come JPEG
Città #
Ashburn 2.315
Woodbridge 1.767
Singapore 1.659
Ann Arbor 1.536
Hong Kong 1.357
Fairfield 1.254
Chandler 1.205
Houston 1.174
San Jose 1.024
Milan 884
Santa Clara 869
Dallas 761
Sofia 629
Hefei 595
Seattle 582
Council Bluffs 546
Beijing 537
Jacksonville 529
Wilmington 458
Shanghai 449
Ottawa 437
New York 428
Cambridge 396
Seoul 394
Boardman 292
Princeton 267
Lawrence 241
Izmir 238
Los Angeles 221
Lauterbourg 208
Nanjing 207
Medford 201
Des Moines 177
Bern 165
Serra 163
Dearborn 148
Rome 141
Istanbul 138
Ho Chi Minh City 120
Buffalo 117
Dong Ket 97
Florence 92
Tokyo 92
Hanoi 90
Jüchen 90
Abidjan 84
São Paulo 84
Vienna 83
Nanchang 78
San Diego 77
Frankfurt am Main 75
Columbus 67
The Dalles 67
Falls Church 63
Pisa 63
Redondo Beach 63
Helsinki 60
London 60
Boulder 54
Redwood City 54
Marseille 49
Kunming 47
Lancaster 47
Tianjin 47
Brussels 46
Dakar 46
Manchester 46
Toronto 43
Bremen 42
Munich 38
Pune 38
San Francisco 37
Chennai 36
Lagos 36
Phoenix 36
Shenyang 36
Chicago 35
Nuremberg 35
Changsha 34
Jiaxing 34
Rio de Janeiro 34
Orem 33
Hebei 32
Naples 31
Verona 31
Baghdad 28
Ogden 27
Brasília 26
Fuzhou 25
Washington 25
Brooklyn 24
Dhaka 24
Norwalk 23
Atlanta 22
Da Nang 22
Philadelphia 21
Amman 20
Auburn Hills 20
Belo Horizonte 20
Hangzhou 20
Totale 27.638
Salva come PNG Salva come JPEG
Nome #
UN INSOLITO CASO DI IPOGLICEMIA IPERINSULINEMICA DA NESIDIOBLASTOSI E INSULINOMA 840
Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria 343
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 309
Lipoprotein Glomerulopathy: Molecular Characterization of Three Italian Patients and Literature Survey 281
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 263
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects 250
Prevalence and risk factors for gestational diabetes assessed by universal screening 242
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants 233
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 227
Valutazione dell'asse ipotalamo-ipofisi-gonadi nel maschio diabetico. 221
CLINICAL AND METABOLIC EFFECTS OF A PILL CONTAINING 30 MCG ETHINYLESTRADIOL PLUS 75 MCG GESTODENE 219
Early detection of left ventricular dysfunction in diabetes mellitus patients with normal ejection fraction, stratified by BMI: A preliminary speckle tracking echocardiography study 216
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 215
Short-term vs. overnight urine collection for screening of urinary albumin excretion rate. 214
Microvascular and acute complications in insulin dependent diabetes mellitus: the EURODIAB IDDM Complications Study 212
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4 211
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment 209
Nutritional intake of 2868 IDDM patients from 30 centres in Europe 207
Optimal therapy of type 2 diabetes: a controversial challenge 207
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 207
THE RELATIONSHIP BETWEEN SMOKING AND MICROVASCULAR COMPLICATIONS IN THE EURODIAB IDDM COMPLICATIONS STUDY 206
Optimizing management of metabolic syndrome to reduce the risk: focus on life-style 206
Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation 205
Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients:the EURODIAB Prospective Complications Study 204
Relationship between total cholesterol level and impairment of intrinsic myocardial contractility, strain and of the active phase of relaxation EUROPEAN HEART JOURNAL AUG 2006 VL 27 SU Suppl. 1 BP 405 EP 406 202
Basal insulin kinetics and glucose-stimulated secretion in untreated and treated diabetic patients and in normal subjects. 201
MICROALBUMINURIA IN TYPE-I (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH AND WITHOUT RETINOPATHY 201
Cardiovascular disease and its risk factors in IDDM in Europe 201
Protein intake and urinary albumin excretion rates in the EURODIAB IDDM complications study 200
EFFECTS OF PANTETHINE ON LIPIDS AND APOLIPOPROTEINS IN HYPERCHOLESTEROLEMIC DIABETIC AND NON DIABETIC-PATIENTS 199
An optimized method to measure glycosylproteins: HPLC assay of 5-hydroxymethil-2-furfuraldehyde (5-HMF). 199
Diabete ed educazione: ruolo ed utilità clinica dell'educazione formale 198
Albuminuria estimated from proteinuria in diabetics. Is it a real alternative in clinical practice? 198
Diabetes programme facts and figures 198
Diabete e disturbi dell'attivita' sessuale 197
Enzimuria e tubulopatia diabetica: più di un semplice sospetto. 197
QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. 197
C-reactive protein and metabolic syndrome in women with previous gestational diabetes 196
PRAVASTATIN VS GEMFIBROZIL IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA - THE ITALIAN MULTICENTER PRAVASTATIN STUDY-I 195
Left ventricular dysfunction in normotensive young adult patients with well-controlled type-I diabetes EUROPEAN HEART JOURNAL AUG 2006 VL 27 SU Suppl. 1 BP 535 EP 535 195
PREVALENCE AND TYPE OF SEXUAL DYSFUNCTIONS IN DIABETIC MALES - A STANDARDIZED CLINICAL APPROACH 193
Genetically determined absence of HDL-cholesterol and coronary atherosclerosis 193
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus 193
Impaired brain plasticity in obesity: effects of bariatric surgery and gut hormones 193
CLINICAL AND METABOLIC STUDY OF A NEW PILL CONTAINING 20 MCG ETHINYLESTRADIOL PLUS 0.150 MG DESOGESTREL 192
Interaction of DIO2 T92A and PPARgamma2 P12A polymorphisms in the modulation of metabolic syndrome 192
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 192
Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The Eurodiab Prospective Complications Study(PCS) 191
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus 191
Metabolic regulation of GLP-1 and PC1/3 in pancreatic α-cell line 191
Valutazione del grado di conoscenza basale della malattia diabetica in pazienti ambulatoriali. 190
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency 188
Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study 188
Basal insulin and cardiovascular and other outcomes in dysglycemia 188
Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial 187
Repeatability of three-day dietary records in the EURODIAB IDDM complications study 187
Circulating lipid levels and severity of diabetic retinopathy in type I diabetes mellitus. 186
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance 185
BLOOD-PRESSURE, RETINOPATHY AND URINARY ALBUMIN EXCRETION IN IDDM - THE EURODIAB IDDM COMPLICATIONS STUDY 185
Intermediate metabolism in normal pregnancy and in gestational diabetes 185
Which method for 'microalbuminuria' in diabetes mellitus? 184
Dietary habits in type 2 diabetes mellitus: how is adherence to dietary recommendations? 184
Endothelial progenitor cells and endothelial dysfunction in prediabetic and newly diagnosed type 2 diabetic subjects 184
Insulin Resistance and Lipid Disorders 184
Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study 184
Fibrinogen and von Willebrand factor in IDDM: Relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: The EURODIAB IDDM complications study 183
Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study 181
SIRT1 rs7896005 polymorphism may be related to coronary artery disease in Caucasians with type 2 diabetes, without affecting all-cause mortality. 181
Prognostic implications of diabetes phenotyping: new concepts for an old disease 180
Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM 180
Radiofrequency-based estimates of local common carotid stiffness and intima-media thickness: implications for detecting early vascular involvement in hypertension and diabetes 179
Circulating endothelial progenitor cells (EPCs) in subjects with impaired glucose regulation (Pre-Diabetes) 178
Divergent changes in expression of antioxidant enzymes in human EPCs and HUVECs exposed to high glucose 178
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes 178
Influence of severe obesity on circulating endothelial progenitor cells levels and effects of bariatric surgery 178
Diabetic ketoacidosis and acute pancreatitis associated with antipsychotic drugs: report of a case 178
A natural apolipoprotein A-I variant, apoA-I(L141R)(Pisa), interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta(1)-HDL and influences efflux of cholesterol into plasma 176
Endothelial progenitor cells in subjects with pre-diabetes 176
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes 176
The EURODIAB IDDM Complications Study Group. Prevalence of Q-T Interval Dispersion in Type 1 Diabetes and Its Relation With Cardiac Ischemia 175
Human EPCs and HUVECs exposed to high glucose: expression of antioxidative enzymes 174
Effects of guar-pasta on serum lipid levels in obese diabetic and non-diabetic women with normal lipids. 174
Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)(Pisa), and an apolipoprotein A-I null allele in patients with absence of HDL, cholesterol, corneal opacifications, and coronary heart disease 173
Factitious hypoglycemia in an insulin-dependent woman in the eighth week of gestation 172
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial. 171
Il piede diabetico: diagnosi e terapia. 170
The EURODIAB Prospective Complications Study Group. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes 170
EFFECTS OF LOW-DOSES OF TIADENOLO IN DIABETIC AND NON-DIABETIC PATIENTS WITH VARIOUS TYPES OF HYPERLIPOPROTEINEMIAS 169
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance 169
Hyperglycaemia and cardiovascular risk 169
Primary Prevention of Cardiovascular Disease in People With Dysglycemia 169
Risposta del GH al GHRH, alla clonidina ed al TRH nel diabete mellito tipo I. 168
Early Systolic dysfunction in asymptomatic type 1 diabetic patients DIABETES JUN 2006 VL 55 SU Suppl. 1 BP A153 EP A153 168
Prevalence of the metabolic syndrome among Italian adults according to ATP III definition 168
Probiotic Lisosan G preserves functional properties of human endo- thelial progenitor cells exposed to lipopolysaccharides 167
Effects of tiadenolo on hypercholesterolemic diabetic and non-diabetic patients. 166
Association between a metabolic syndrome severity score and all- cause mortality in type 1 diabetes: a 10-year follow-up study 166
A frequency study of diabetic retinopathy in Pisa County. 165
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 165
Guar-pasta: a new diet for obese subjects? 165
Totale 20.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.303
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.474 0 0 0 178 563 361 77 130 153 74 161 777
2022/20233.310 447 383 181 325 402 466 45 257 515 20 222 47
2023/20242.917 463 318 405 208 440 468 77 112 61 70 77 218
2024/20257.544 42 311 162 465 634 695 536 419 666 943 930 1.741
2025/20267.506 591 1.122 1.006 593 656 729 1.256 297 325 595 214 122
2026/20273.486 182 820 1.608 876 0 0 0 0 0 0 0 0
Totale 40.122